The Effects of Caffeine on Physical Performance of Ice Hockey Players

Caffeine Clinical Trial

— cafhoc  

Official title:

The Effects of Caffeine on Physical Performance of Ice Hockey Players: A Cross-over Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05170139
• Other study ID #: Caffeinehockey
• Status: Completed
• Phase: N/A
• Start date: March 1, 2021
• Est. completion date: May 30, 2021

Study information

• Verified date: May 2023
• Source: Universidad de Zaragoza
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To date, only one study has evaluated the effect of caffeine supplementation on athletic performance in ice hockey players finding a lack of ergogenic effect. This lack of effect is surprising as caffeine has been suggested to be an effective and safe nutritional supplement to improve physical performance in both trained and untrained individuals. Therefore, the aim of the present study is to evaluate the effect of acute caffeine ingestion (3mg/kg body mass). Thirteen elite adult ice-hockey male players will perform specific ice hockey performance tests in two separate days. On both occasions players will ingest 330 ml of water with lemon powertabs isostar® (86 kcal / 19g of carbohydrates) tablets, which will include in one of these days 3 mg/kg body mass of anhydrous caffeine. Players will perform a 35-m sprint, an agility test (Weave agility - slalom with puck), and a reaction test.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 13
• Est. completion date: May 30, 2021
• Est. primary completion date: April 30, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• Over 18 years,

• Male

• Play in the Spanish ice hockey first division.

Exclusion Criteria:

• Participants taking drugs containing ephedrine or antibiotics.

• Having suffered a musculoskeletal injury in the 3 months prior to the tests.

Related Conditions & MeSH terms

• Athletic Performance
• Caffeine

Intervention

Dietary Supplement:
• Caffeine
Participants will ingest a drink with 3mg/kg of body weight mixed with carbohydrates
• Placebo drink
Participants will ingest the exact same drink without caffeine

Locations

Country	Name	City	State
Spain	Universidad de Zaragoza	Zaragoza

Sponsors (1)

Lead Sponsor	Collaborator
Universidad de Zaragoza

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	35m sprint time (Seconds)	Time that participants take to skate 35 meters. Data will be collected with photoelectric cells	One day (one hour post caffeine consumption)
Primary	Agility test time (Seconds)	Time that participants take to perform an agility circuit. Data will be collected with photoelectric cells	One day (one hour post caffeine consumption)
Primary	Reaction test time (seconds)	Time that participants take to complete a reaction test circuit. Data will be collected with photoelectric cells.	One day (one hour post caffeine consumption)